Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

EU regulator backs approval of COVID-19 drugs from Regeneron-Roche, Celltrion

Nov 11 (Reuters) - Europe's drug regulator on Thursday
recommended https://www.ema.europa.eu/en/news/covid-19-ema-recommends-authorisation-two-monoclonal-antibody-medicines
 approving two COVID-19 therapies based on monoclonal
antibodies, one developed by U.S. biotech firm Regeneron
 REGN.O  and Swiss giant Roche  ROG.S  and another from South
Korea's Celltrion  091990.KQ .
    The news comes after Reuters reported this week the approval
was imminent amid a spike in coronavirus infections.
 urn:newsml:reuters.com:*:nL1N2S00ZV

 (Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun
Koyyur)
 ((Pushkala.A@thomsonreuters.com; Twitter: @pullthekart; Mobile:
+91 852 751 3793 ;))

Recent news on Celltrion Healthcare Co

See all news